risedronate

(redirected from Risedronate sodium)
Also found in: Medical.

ri·sed·ro·nate

 (rĭ-sĕd′rə-nāt′)
n.
A bisphosphonate drug, C7H11NO7P2, that inhibits bone resorption and is used in the form of its sodium salt to treat and prevent osteoporosis in postmenopausal women.

[Perhaps (py)ri(dine) + -se-, origin unknown + (hy)dr(oxy) + (bisphosph)onate.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

risedronate, risedronate sodium

(USAN), risedronic acid (INN) n risedronato, risedronato sódico, ácido risedrónico (INN)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Samreen Abbas, daughter of Abbas Ali, has been awarded PhD degree in the subject of Mathematics after approval of her thesis entitled 'Digital Image Processing Using Soft Computing Techniques and Spline Representations'; Muhammad Khurram Shahzad, son of Muhammad Sharif, awarded degree in Pharmacy (Pharmaceutics) after approval of his thesis entitled 'Development and Analysis of Risedronate Sodium Loaded Multi-Particulate Drug Delivery System Using Superabsorbent Polymer'.
Samreen Abbas, daughter of Abbas Ali, has been awarded PhD degree in the subject of Mathematics after approval of her thesis entitled 'Digital Image Processing Using Soft Computing Techniques and Spline Representations'; Mohammad Khurram Shahzad, son of Mohammad Sharif, awarded degree in Pharmacy (Pharmaceutics) after approval of his thesis entitled 'Development and Analysis of Risedronate Sodium Loaded Multi-Particulate Drug Delivery System Using Superabsorbent Polymer'.Abdul Aziz, son of Rasheed Ahmad, in the subject of Islamic Studies.
The patients were prevented from weight bearing by using forearm crutches and received medical treatment including diclofenac sodium, acetylsalicylic acid, and risedronate sodium in addition to hyperbaric oxygen therapy.
As a member of the new generation of osteoporosis drugs, risedronate sodium is used for the treatment and prevention of osteoporosis in postmenopausal women.
As of December 2014, Teva's Actonel (risedronate sodium) Tablets had annual sales of approximately USD157m in the US, according to IMS data.
Hay et al., "Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects," Clinical Therapeutics, vol.
The products affected are those approved for osteoporosis indications, such as alendronate (Fosamax), alendronate and cholecalciferol (Fosamax Plus D), risedronate sodium (Actonel), risedronate sodium with calcium carbonate (Actonel with Calcium), ibandronate sodium (Boniva), risedronate sodium (Atelvia), pamidronate injection (Aredia), and zoledronic acid injection (Reclast), as well as generic formulations of those drugs.
The products affected are those approved for osteoporosis indications, such as alendronate (Fosamax), alendronate and cholecalciferol (Fosamax Plus D), risedronate sodium (Actonel), rise-dronate sodium with calcium carbonate (Actonel with Calcium), ibandronate sodium (Boniva), risedronate sodium (Atelvia), pamidronate injection (Are-dia), and zoledronic acid injection (Re-clast), as well as generic formulations of those drugs.
Risedronate sodium is approved by the FDA for the prevention and treatment (5 mg daily tablet; 35 mg weekly tablet; 35 mg weekly tablet packaged with 6 tablets of 500 nag calcium carbonate; 75 mg tablets on two consecutive days every month; and 150 mg monthly tablet) of postmenopausal osteoporosis.